1-154167938-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM4PP5_Moderate
The NM_152263.4(TPM3):āc.857A>Cā(p.Ter286SerextTer57) variant causes a stop lost, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,810 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (ā ).
Frequency
Consequence
NM_152263.4 stop_lost, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPM3 | NM_152263.4 | c.857A>C | p.Ter286SerextTer57 | stop_lost, splice_region_variant | 10/10 | ENST00000651641.1 | NP_689476.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPM3 | ENST00000651641.1 | c.857A>C | p.Ter286SerextTer57 | stop_lost, splice_region_variant | 10/10 | NM_152263.4 | ENSP00000498577 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247130Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134304
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461810Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727212
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Congenital myopathy 4B, autosomal recessive Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2008 | - - |
Congenital myopathy with fiber type disproportion;C5829889:Congenital myopathy 4B, autosomal recessive Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 11, 2023 | This sequence change disrupts the translational stop signal of the TPM3 mRNA. It is expected to extend the length of the TPM3 protein by 57 additional amino acid residues. This variant is present in population databases (rs199474720, gnomAD 0.009%). This protein extension has been observed in individuals with autosomal recessive nemaline myopathy and congenital fiber type disproportion (PMID: 12196661, 19953533). ClinVar contains an entry for this variant (Variation ID: 12447). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this protein extension affects TPM3 function (PMID: 12196661, 21357678). This variant results in an extension of the TPM3 protein. Other variant(s) that result in a similarly extended protein product (p.*286Lysext*57) have been observed in individuals with TPM3-related disease (PMID: 33124102). This suggests that these extensions may be clinically significant. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
not provided Other:1
not provided, no classification provided | literature only | TPM3 homepage - Leiden Muscular Dystrophy pages | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at